Introduction Persons aged more than 65 years may be more prone to suffer from chronic
diseases and comorbidities (as demonstrated by the recent COVID-19 pandemics) and are …

Purpose Statins are among the most frequently prescribed medications internationally. Older
people are commonly prescribed multiple medications and are at an increased risk of drug …

Inhibitors of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase,
commonly known as statins, are widely used in both primary and secondary prevention of …

Background and objective Elderly patients may be at higher risk of drug-drug interactions
(DDIs) because of polypharmacy. This study evaluated age-specific differences in the …

Introduction: Statins reduce the risk of cardiovascular morbidity and mortality in patients with
or at risk for cardiovascular disease and their use is expanding, especially in elderly. Statins …

Background A significant proportion of older people are prescribed statins and are also
exposed to polypharmacy, placing them at increased risk of statin–drug interactions …

The elderly differ from younger people in the relation of cholesterol to heart disease and
mortality. Clinical trial evidence supports epidemiological findings in showing that high …

Cardiovascular disease (CVD) is estimated to remain as the main cause of death in
developed nations over the next 30 years, with increased prevalence in the older …

Abstract Purpose of Review Our aim was to examine the current evidence behind
prescribing statins to individuals over 65 years of age with emphasis on those older than 75 …

The elderly population is increasing worldwide, with subjects> 65 years of age constituting
the fastest-growing age group. Furthermore, the elderly face the greatest risk and burden of …